SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (883)6/7/1998 8:45:00 AM
From: John Bloxom  Respond to of 10280
 
SEPR management, per my broker, is unaware of any development that is responsible for the recent decline in price.

The past three substantial price declines in this issue have been 22, 22 and 23 percent (measured from the high close before the drop to the low close before the recovery). That suggests that support will be at 36 and change.

Regards,

John



To: Biomaven who wrote (883)6/9/1998 10:48:00 AM
From: John R. Sashko  Read Replies (1) | Respond to of 10280
 
TA shows SEPR's market is oversold and reversal underway. I closed AHP and PFE calls yesterday and will roll the profits into SEPR today.

Long term, this is a steal at these prices but one must expect volatility in a stock like this. Best way to play is with options.

Happy Trading

John


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News